Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Cumberland Pharmaceuticals Inc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +13 vs. Q4 2024
- Shares held
- 4.28M
- +2.44M (+132.4%) vs. Q4 2024
- Total value
- $18.1M
- +$13.8M (+315.9%) vs. Q4 2024
- New holders
- 14
- 4 more added
- Sold out
- 1
- 8 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $16.0M |
| Q1 2026 | 29 | $8.97M |
| Q4 2025 | 27 | $11.8M |
| Q3 2025 | 30 | $10.6M |
| Q2 2025 | 31 | $12.3M |
| Q1 2025 | 33 | $18.1M |
| Q4 2024 | 20 | $4.36M |
| Q3 2024 | 22 | $2.61M |
| Q2 2024 | 23 | $3.18M |
| Q1 2024 | 23 | $3.63M |
| Q4 2023 | 25 | $3.89M |
| Q3 2023 | 21 | $4.17M |
| Q2 2023 | 23 | $3.52M |
| Q1 2023 | 21 | $4.77M |
| Q4 2022 | 23 | $5.61M |
| Q3 2022 | 17 | $5.89M |
| Q2 2022 | 22 | $5.62M |
| Q1 2022 | 26 | $8.17M |
| Q4 2021 | 26 | $13.2M |
| Q3 2021 | 23 | $7.43M |
| Q2 2021 | 28 | $8.36M |
| Q1 2021 | 31 | $9.77M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Cumberland Pharmaceuticals Inc; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $4 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 19 | $80 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 68 | $288 | 0.00% | +3+4.6% | Added |
| Wells Fargo & Company | 250 | $1.06K | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 437 | $2.00K | 0.00% | 00.0% | Unchanged |
| Centiva Capital, LP | 1,600 | $6.77K | 0.00% | +1,600 | New |
| Morgan Stanley | 2,660 | $11.3K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,337 | $22.6K | 0.00% | −2,858−34.9% | Reduced |
| Wiley Bros.-Aintree Capital, LLC | 11,000 | $48.5K | 0.00% | +11,000 | New |
| Schonfeld Strategic Advisors LLC | 17,900 | $75.7K | 0.00% | +17,900 | New |
| Simplex Trading, LLC | 19,100 | $80.0K | 0.00% | +19,100 | New |
| Northern Trust Corp | 19,603 | $82.9K | 0.00% | +3,891+24.8% | Added |
| Cresset Asset Management, LLC | 19,975 | $84.5K | 0.00% | −2,300−10.3% | Reduced |
| Two Sigma Investments, LP | 22,755 | $96.3K | 0.00% | −14,894−39.6% | Reduced |
| Citadel Advisors LLC | 25,814 | $109.2K | 0.00% | +25,814 | New |
| Susquehanna International Group, LLP | 28,939 | $122.4K | 0.00% | +28,939 | New |
| BlackRock, Inc. | 32,658 | $138.1K | 0.00% | −9,923−23.3% | Reduced |
| State Street Corp | 33,700 | $142.6K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 49,137 | $207.0K | 0.00% | −139,027−73.9% | Reduced |
| Walleye Capital LLC | 70,419 | $297.9K | 0.00% | +70,419 | New |
| EAM Investors, LLC | 71,776 | $303.6K | 0.05% | +71,776 | New |
| Bank of New York Mellon Corp | 72,513 | $306.7K | 0.00% | −2,756−3.7% | Reduced |
| Geode Capital Management, LLC | 99,091 | $419.2K | 0.00% | +24,786+33.4% | Added |
| Adage Capital Partners GP, L.L.C. | 150,000 | $634.5K | 0.00% | +150,000 | New |
| Berkshire Asset Management LLC | 153,810 | $692.1K | 0.03% | +153,810 | New |
| Bridgeway Capital Management, LLC | 184,155 | $779.0K | 0.02% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 223,798 | $946.7K | 0.03% | +223,798 | New |
| J. Goldman & Co LP | 241,481 | $1.02M | 0.04% | +241,481 | New |
| Dimensional Fund Advisors LP | 252,189 | $1.07M | 0.00% | −20,780−7.6% | Reduced |
| Vanguard Group Inc | 416,569 | $1.76M | 0.00% | +42,318+11.3% | Added |
| Renaissance Technologies LLC | 503,363 | $2.13M | 0.00% | −3,800−0.7% | Reduced |
| Ikarian Capital, LLC | 740,000 | $3.13M | 1.02% | +740,000 | New |
| Millennium Management LLC | 809,897 | $3.43M | 0.00% | +809,897 | New |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,218−100.0% | Sold out |